Return On Equity of Eledon Pharmaceuticals, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eledon Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Eledon Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -154%, a 389% decline year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2024 was 279%.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2023 was -441%, a 490% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Return On Equity for 2022 was -75%, a 278% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -154% -207% -389% 01 Jul 2025 30 Sep 2025
Q2 2025 31% -264% -90% 01 Apr 2025 30 Jun 2025
Q1 2025 -98% -1407% -108% 01 Jan 2025 31 Mar 2025
Q4 2024 279% +721% 01 Oct 2024 31 Dec 2024
Q3 2024 53% +379% 01 Jul 2024 30 Sep 2024
Q2 2024 294% +500% 01 Apr 2024 30 Jun 2024
Q1 2024 1309% +1400% 01 Jan 2024 31 Mar 2024
Q4 2023 -441% -366% -490% 01 Oct 2023 31 Dec 2023
Q3 2023 -326% -300% -1195% 01 Jul 2023 30 Sep 2023
Q2 2023 -205% -182% -771% 01 Apr 2023 30 Jun 2023
Q1 2023 -91% -70% -326% 01 Jan 2023 31 Mar 2023
Q4 2022 -75% -55% -278% 01 Oct 2022 31 Dec 2022
Q3 2022 -25% -8% -44% 01 Jul 2022 30 Sep 2022
Q2 2022 -24% -4% -21% 01 Apr 2022 30 Jun 2022
Q1 2022 -21% +1% +6.1% 01 Jan 2022 31 Mar 2022
Q4 2021 -20% +19% +49% 01 Oct 2021 31 Dec 2021
Q3 2021 -17% +144% +89% 01 Jul 2021 30 Sep 2021
Q2 2021 -19% +143% +88% 01 Apr 2021 30 Jun 2021
Q1 2021 -23% +130% +85% 01 Jan 2021 31 Mar 2021
Q4 2020 -39% +92% +70% 01 Oct 2020 31 Dec 2020
Q3 2020 -162% -40% -32% 01 Jul 2020 30 Sep 2020
Q2 2020 -162% -46% -40% 01 Apr 2020 30 Jun 2020
Q1 2020 -153% -52% -52% 01 Jan 2020 31 Mar 2020
Q4 2019 -131% -60% -83% 01 Oct 2019 31 Dec 2019
Q3 2019 -122% -67% -120% 01 Jul 2019 30 Sep 2019
Q2 2019 -116% -64% -125% 01 Apr 2019 30 Jun 2019
Q1 2019 -100% -34% -52% 01 Jan 2019 31 Mar 2019
Q4 2018 -72% -11% -18% 01 Oct 2018 31 Dec 2018
Q3 2018 -56% +36% +39% 01 Jul 2018 30 Sep 2018
Q2 2018 -52% +23% +31% 01 Apr 2018 30 Jun 2018
Q1 2018 -66% -30% -83% 01 Jan 2018 31 Mar 2018
Q4 2017 -60% +1% +2.2% 01 Oct 2017 31 Dec 2017
Q3 2017 -91% -8% -10% 01 Jul 2017 30 Sep 2017
Q2 2017 -74% +11% +13% 01 Apr 2017 30 Jun 2017
Q1 2017 -36% +47% +56% 01 Jan 2017 31 Mar 2017
Q4 2016 -62% +11% +15% 01 Oct 2016 31 Dec 2016
Q3 2016 -83% -36% -79% 01 Jul 2016 30 Sep 2016
Q2 2016 -86% -49% -133% 01 Apr 2016 30 Jun 2016
Q1 2016 -83% 01 Jan 2016 31 Mar 2016
Q4 2015 -73% 01 Oct 2015 31 Dec 2015
Q3 2015 -46% 01 Jul 2015 30 Sep 2015
Q2 2015 -37% 01 Apr 2015 30 Jun 2015

Eledon Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 279% +721% 01 Jan 2024 31 Dec 2024
2023 -441% -366% -490% 01 Jan 2023 31 Dec 2023
2022 -75% -55% -278% 01 Jan 2022 31 Dec 2022
2021 -20% +19% +49% 01 Jan 2021 31 Dec 2021
2020 -39% +92% +70% 01 Jan 2020 31 Dec 2020
2019 -131% -60% -83% 01 Jan 2019 31 Dec 2019
2018 -72% -11% -18% 01 Jan 2018 31 Dec 2018
2017 -60% -41% -215% 01 Jan 2017 31 Dec 2017
2016 -19% +53% +74% 01 Jan 2016 31 Dec 2016
2015 -73% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.